Amplyx, now a subsidiary of Pfizer Inc.

📍 San Diego, United States👥 9 employees💰 Last funded Jul 2017
Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today’s therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx’s leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions. For more information on Amplyx, please visit our website at www.amplyx.com
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Amplyx, now a subsidiary of Pfizer Inc.?
Amplyx, now a subsidiary of Pfizer Inc. has 2 investors on record on gritt.io.
When did Amplyx, now a subsidiary of Pfizer Inc. last raise funding?
The most recent investment in Amplyx, now a subsidiary of Pfizer Inc. recorded on gritt.io was in July 2017.
What industry is Amplyx, now a subsidiary of Pfizer Inc. in?
Amplyx, now a subsidiary of Pfizer Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Amplyx, now a subsidiary of Pfizer Inc. based?
Amplyx, now a subsidiary of Pfizer Inc. is headquartered in San Diego, United States.